Cholangiocarcinoma — Trials

Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

760 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 210
Recruiting: 120
Ph III recruiting: 7
Growth YoY: +17.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (106)

clinicaltrialsPublishedShowing 751–760 of 760 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00733200	Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?	completed	N/A	—	Huazhong University of Science and TechnologyOTHER	0	Dec 11, 2009	clinicaltrials
NCT00973713	Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol(RADiChol)	unknown	Phase 2	27	Austin HealthOTHER_GOV	1	Sep 9, 2009	clinicaltrials